{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-06",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Bridgewater",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "63803",
      "recalling_firm": "sanofi-aventis US, Inc.",
      "address_1": "Route 202-206",
      "address_2": "N/A",
      "postal_code": "08807",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Other",
      "distribution_pattern": "Worldwide distribution.",
      "recall_number": "Z-0609-2013",
      "product_description": "Diamigo i-Phone App     The Diamigo app was intended for use as an educational tool in the management of diabetes.",
      "product_quantity": "1600 downloads (140 US; 1460 Foreign)",
      "reason_for_recall": "Diamigo, a software application, was released through the i-Phone Global Store which inadvertently allowed global access to the application as opposed to the original intended restriction of access to Brazil.",
      "recall_initiation_date": "20120921",
      "center_classification_date": "20121221",
      "termination_date": "20150722",
      "report_date": "20130102",
      "code_info": "n/a"
    }
  ]
}